Cellular localization of the herpes simplex virus ICP0 protein dictates its ability to block IRF3-mediated innate immune responses

PLoS ONE

Volumn 5, Issue 4, 2010, Pages

  Paladino, Patrick ^a   Collins, Susan E ^a   Mossman, Karen L ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFECTED CELL PROTEIN 0; INTERFERON REGULATORY FACTOR 3; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN; IMMEDIATE EARLY PROTEIN; IRF3 PROTEIN, HUMAN; PROTEASOME;

ARTICLE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; ENZYME INHIBITION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; INNATE IMMUNITY; LUNG FIBROBLAST; NONHUMAN; PROTEIN PROCESSING; VIRUS CELL INTERACTION; VIRUS ENTRY; ACTIVE TRANSPORT; CELL CULTURE; DRUG ANTAGONISM; HERPES SIMPLEX; IMMUNOLOGY; METABOLISM;

ACTIVE TRANSPORT, CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; PROTEASOME ENDOPEPTIDASE COMPLEX; VIRAL PROTEINS;

EID: 77956398377     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010428     Document Type: Article

References (73)

1. Pichlmair A, Reis e Sousa C (2007) Innate recognition of viruses. Immunity 27: 370-383.
2. Ranjan P, Bowzard JB, Schwerzmann JW, Jeisy-Scott V, Fujita T, et al. (2009) Cytoplasmic nucleic acid sensors in antiviral immunity. Trends Mol Med 15: 359-368.
3. Collins S, Noyce R, Mossman K (2004) Innate cellular response to virus particle entry requires IRF3 but not virus replication. J Virol 78: 1706-1717.
4. Preston C, Harman A, Nicholl M (2001) Activation of interferon response factor- 3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 75: 8909-8916.
5. Mossman KL, Macgregor PF, Rozmus JJ, Goryachev AB, Edwards AM, et al. (2001) Herpes simplex virus triggers and then disarms a host antiviral response. J Virol 75: 750-758.
6. Nicholl M, Robinson L, Preston C (2000) Activation of cellular interferon- responsive genes after infection of human cells with herpes simplex virus type 1. J Gen Virol 81: 2215-2218.
7. Hiscott J (2007) Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev 18: 483-490.
8. Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644-658.
9. Honda K, Takaoka A, Taniguchi T (2006) Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25: 349-360.
10. Lin R, Heylbroeck C, Pitha P, Hiscott J (1998) Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 18: 2986-2996.
11. Lu G, Reinert JT, Pitha-Rowe I, Okumura A, Kellum M, et al. (2006) ISG15 enhances the innate antiviral response by inhibition of IRF-3 degradation. Cell Mol Biol (Noisy-le-grand) 52: 29-41.
12. Grandvaux N, Servant M, tenOever B, Sen G, Balachandran S, et al. (2002) Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J Virol 76: 5532-5539.
13. Peters K, Smith H, Stark G, Sen G (2002) IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA. Proc Natl Acad Sci USA 99: 6322-6327.
14. Roy CR, Mocarski ES (2007) Pathogen subversion of cell-intrinsic innate immunity. Nat Immunol 8: 1179-1187.
15. Roizman B, Gu H, Mandel G (2005) The first 30 minutes in the life of a virus: unREST in the nucleus. Cell Cycle 4: 1019-1021.
16. Hagglund R, Roizman B (2004) Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1. J Virol 78: 2169-2178.
17. Everett R (2000) ICP0, a regulator of herpes simplex virus during lytic and latent infection. Bioessays 22: 761-770.
18. Paladino P, Mossman K (2009) Mechanisms Employed by HSV-1 to Inhibit the Interferon Response. Journal of Interferon & Cytokine Research.
19. Lopez P, Van Sant C, Roizman B (2001) Requirements for the nuclear- cytoplasmic translocation of infected-cell protein 0 of herpes simplex virus 1. J Virol 75: 3832-3840.
20. Kawaguchi Y, Van Sant C, Roizman B (1997) Herpes simplex virus 1 alpha regulatory protein ICP0 interacts with and stabilizes the cell cycle regulator cyclin D3. J Virol 71: 7328-7336.
21. Kawaguchi Y, Bruni R, Roizman B (1997) Interaction of herpes simplex virus 1 alpha regulatory protein ICP0 with elongation factor 1delta: ICP0 affects translational machinery. J Virol 71: 1019-1024.
22. Maul GG, Everett RD (1994) The nuclear location of PML, a cellular member of the C3HC4 zinc-binding domain protein family, is rearranged during herpes simplex virus infection by the C3HC4 viral protein ICP0. J Gen Virol 75 (Pt6): 1223-1233.
23. Boutell C, Sadis S, Everett R (2002) Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro. J Virol 76: 841-850.
24. Everett RD (2000) ICP0 induces the accumulation of colocalizing conjugated ubiquitin. J Virol 74: 9994-10005.
25. Everett RD, Orr A, Preston CM (1998) A viral activator of gene expression functions via the ubiquitin-proteasome pathway. EMBO J 17: 7161-7169.
26. Sobol PT, Mossman KL (2006) ICP0 prevents RNase L-independent rRNA cleavage in herpes simplex virus type 1-infected cells. J Virol 80: 218-225.
27. Everett RD (1988) Analysis of the functional domains of herpes simplex virus type 1 immediate-early polypeptide Vmw110. Journal of Molecular Biology 202: 87-96.
28. Davido DJ, Leib DA, Schaffer PA (2002) The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0. J Virol 76: 1077-1088.
29. Advani SJ, Hagglund R, Weichselbaum RR, Roizman B (2001) Posttranslational processing of infected cell proteins 0 and 4 of herpes simplex virus 1 is sequential and reflects the subcellular compartment in which the proteins localize. J Virol 75: 7904-7912.
30. Boutell C, Everett R, Hilliard J, Schaffer P, Orr A, et al. (2008) Herpes simplex virus type 1 ICP0 phosphorylation mutants impair the E3 ubiquitin ligase activity of ICP0 in a cell type-dependent manner. J Virol 82: 10647-10656.
31. Davido D, von Zagorski W, Lane W, Schaffer P (2005) Phosphorylation site mutations affect herpes simplex virus type 1 ICP0 function. J Virol 79: 1232-1243.
32. Mossman KL, Saffran HA, Smiley JR (2000) Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J Virol 74: 2052-2056.
33. Lin R, Noyce RS, Collins SE, Everett RD, Mossman KL (2004) The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 78: 1675-1684.
34. Eidson K, Hobbs W, Manning B, Carlson P, DeLuca N (2002) Expression of herpes simplex virus ICP0 inhibits the induction of interferon-stimulated genes by viral infection. J Virol 76: 2180-2191.
35. Melroe GT, Silva L, Schaffer PA, Knipe DM (2007) Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN-beta induction. Virology 360: 305-321.
36. Melroe G, DeLuca N, Knipe D (2004) Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production. J Virol 78: 8411-8420.
37. Everett RD, Orr A (2009) Herpes Simplex Virus Type 1 Regulatory Protein ICP0 Aids Infection in Cells with a Preinduced Interferon Response but Does Not Impede Interferon-Induced Gene Induction. J Virol 83: 4978-4983.
38. Noyce RS, Collins SE, Mossman KL (2009) Differential modification of interferon regulatory factor 3 following virus particle entry. J Virol 83: 4013-4022.
39. Reimer T, Brcic M, Schweizer M, Jungi TW (2008) poly(I:C) and LPS induce distinct IRF3 and NF-kappaB signaling during type-I IFN and TNF responses in human macrophages. J Leukoc Biol 83: 1249-1257.
40. Fridman A, Tang L, Kulaeva O, Ye B, Li Q, et al. (2006) Expression Profiling Identifies Three Pathways Altered in Cellular Immortalization: Interferon, Cell Cycle, and Cytoskeleton. Journals of Gerontology Series A: Biological Sciences and Medical Sciences 61: 879.
41. Daubeuf S, Singh D, Tan Y, Liu H, Federoff HJ, et al. (2009) HSV ICP0 recruits USP7 to modulate TLR-mediated innate response. Blood 113: 3264-3275.
42. Kalamvoki M, Qu J, Roizman B (2008) Translocation and colocalization of ICP4 and ICP0 in cells infected with herpes simplex virus 1 mutants lacking glycoprotein E, glycoprotein I, or the virion host shutoff product of the UL41 gene. J Virol 82: 1701-1713.
43. Guo J, Peters K, Sen G (2000) Induction of the human protein P56 by interferon, double-stranded RNA, or virus infection. Virology 267: 209-219.
44. Servant M, ten Oever B, LePage C, Conti L, Gessani S, et al. (2001) Identification of distinct signaling pathways leading to the phosphorylation of interferon regulatory factor 3. J Biol Chem 276: 355-363.
45. Everett RD, Parsy M-L, Orr A (2009) Analysis of the Functions of Herpes Simplex Virus Type 1 Regulatory Protein ICP0 That Are Critical for Lytic Infection and Derepression of Quiescent Viral Genomes. J Virol 83: 4963-4977.
46. Van Sant C, Kawaguchi Y, Roizman B (1999) A single amino acid substitution in the cyclin D binding domain of the infected cell protein no. 0 abrogates the neuroinvasiveness of herpes simplex virus without affecting its ability to replicate. Proc Natl Acad Sci USA 96: 8184-8189.
47. Yoneyama M, Suhara W, Fukuhara Y, Fukuda M, Nishida E, et al. (1998) Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. Embo J 17: 1087-1095.
48. Lin R, Mamane Y, Hiscott J (1999) Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and auto- inhibitory domains. Molecular and Cellular Biology 19: 2465-2474.
49. Everett RD, Freemont P, Saitoh H, Dasso M, Orr A, et al. (1998) The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J Virol 72: 6581-6591.
50. Killington RA, Yeo J, Honess R, Watson DH, Duncan BE, et al. (1977) Comparative analyses of the proteins and antigens of five herpesviruses. J Gen Virol 37: 297-310.
51. Becker Y, Asher Y, Cohen Y, Weinberg-Zahlering E, Shlomai J (1977) Phosphonoacetic acid-resistant mutants of herpes simplex virus: effect of phosphonoacetic acid on virus replication and in vitro deoxyribonucleic acid synthesis in isolated nuclei. Antimicrob Agents Chemother 11: 919-922.
52. Hay J, Brown SM, Jamieson AT, Rixon FJ, Moss H, et al. (1977) The effect of phosphonoacetic acid on herpes viruses. J Antimicrob Chemother 3 Suppl A: 63-70.
53. Leinbach SS, Reno JM, Lee LF, Isbell AF, Boezi JA (1976) Mechanism of phosphonoacetate inhibition of herpesvirus-induced DNA polymerase. Bio- chemistry 15: 426-430.
54. DeFilippis V, Früh K (2005) Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3. J Virol 79: 6419-6431.
55. Tsitoura E, Thomas J, Cuchet D, Thoinet K, Mavromara P, et al. (2009) Infection with herpes simplex type 1-based amplicon vectors results in an IRF3/ 7-dependent, TLR-independent activation of the innate antiviral response in primary human fibroblasts. J Gen Virol 90: 2209-2220.
56. Noyce RS, Collins SE, Mossman KL (2006) Identification of a novel pathway essential for the immediate-early, interferon-independent antiviral response to enveloped virions. J Virol 80: 226-235.
57. Paladino P, Cummings DT, Noyce RS, Mossman KL (2006) The IFN- independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 177: 8008-8016.
58. Everett RD, Young DF, Randall RE, Orr A (2008) STAT-1- and IRF-3- dependent pathways are not essential for repression of ICP0-null mutant herpes simplex virus type 1 in human fibroblasts. J Virol 82: 8871-8881.
59. Everett R, Maul G (1994) HSV-1 IE protein Vmw110 causes redistribution of PML. Embo J 13: 5062-5069.
60. Maul G, Guldner H, Spivack J (1993) Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J Gen Virol 74 (Pt 12): 2679-2690.
61. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, et al. (2000) Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13: 539-548.
62. Ehlers B, Kuchler J, Yasmum N, Dural G, Voigt S, et al. (2007) Identification of novel rodent herpesviruses, including the first gammaherpesvirus of Mus musculus. J Virol 81: 8091-8100.
63. Everett R (1989) Construction and characterization of herpes simplex virus type 1 mutants with defined lesions in immediate early gene 1. J Gen Virol 70 (Pt 5): 1185-1202.
64. Reimer T, Schweizer M, Jungi TW (2007) Type I IFN induction in response to Listeria monocytogenes in human macrophages: evidence for a differential activation of IFN regulatory factor 3 (IRF3). J Immunol 179: 1166-1177.
65. Cai W, Schaffer P (1992) Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J Virol 66: 2904-2915.
66. Everett R, Orr A, Elliott M (1991) High level expression and purification of herpes simplex virus type 1 immediate early polypeptide Vmw110. Nucleic Acids Res 19: 6155-6161.
67. Ciufo DM, Mullen MA, Hayward GS (1994) Identification of a dimerization domain in the C-terminal segment of the IE110 transactivator protein from herpes simplex virus. J Virol 68: 3267-3282.
68. Blaho JA, Mitchell C, Roizman B (1993) Guanylylation and adenylylation of the alpha regulatory proteins of herpes simplex virus require a viral beta or gamma function. J Virol 67: 3891-3900.
69. Ogle WO, Ng TI, Carter KL, Roizman B (1997) The UL13 protein kinase and the infected cell type are determinants of posttranslational modification of ICP0. Virology 235: 406-413.
70. Andrews NC, Faller DV (1991) A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res 19: 2499.
71. Kato A, Sakai Y, Shioda T, Kondo T, Nakanishi M, et al. (1996) Initiation of Sendai virus multiplication from transfected cDNA or RNA with negative or positive sense. Genes Cells 1: 569-579.
72. Cai W, Schaffer P (1989) Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J Virol 63: 4579-4589.
73. Stow ND, Stow EC (1986) Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J Gen Virol 67 (Pt12): 2571-2585.